BEGOÑA MARTIN CASTILLO

Projectes

Metabolism and Cancer

Ajuts per donar suport a les activitats dels grups de recerca de Catalunya (SGR-Cat 2021) - Metabolisme i càncer

Codi oficial: VL93FSWZV Start date:01/01/2023 Data fi: 31/12/2024 Investigador/a principal: BEGOÑA MARTIN CASTILLO Organisme finançador: AGENCIA DE GESTIO D'AJUTS UNIV. I RECER. Ajuda: 24,000 €

Publicacions

Metabolism and Cancer , Descriptive epidemiology, genetics and cancer prevention , Precision Oncology in Girona

Bosch-Barrera J, Roqué A, Teixidor E, Carmona-Garcia MC, Arbusà A, Brunet J, Martin-Castillo B, Cuyàs E, Verdura S, Menendez JA

Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin

Pharmaceuticals, 2022, 15 dx.doi.org/10.3390/ph15010019

Metabolism and Cancer

Metformin and breast cancer: an opportunity for pharmacogenetics

Aging-Us, 2022, 14, 5612-5613 dx.doi.org/10.18632/aging.204180

Metabolism and Cancer

Metformin and Breast Cancer: Where Are We Now?

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 dx.doi.org/10.3390/ijms23052705

Metabolism and Cancer

Tramonti A, Cuyàs E, Encinar JA, Pietzke M, Paone A, Verdura S, Arbusà A, Martin-Castillo B, Giardina G, Joven J, Vazquez A, Contestabile R, Cutruzzolà F, Menendez JA

Metformin Is a Pyridoxal-5 '-phosphate (PLP)-Competitive Inhibitor of SHMT2

Cancers, 2021, 13 dx.doi.org/10.3390/cancers13164009

Metabolism and Cancer

Cuyàs E, Verdura S, Martin-Castillo B, Menendez JA

Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology

Frontiers in oncology, 2021, 10, 620641-620641 dx.doi.org/10.3389/fonc.2020.620641

Metabolism and Cancer , Precision Oncology in Girona

Cuyàs E, Verdura S, Martin-Castillo B, Alarcón T, Lupu R, Bosch-Barrera J, Menendez JA

Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy

Cancers, 2020, 12 dx.doi.org/10.3390/cancers12071757

Metabolism and Cancer , Precision Oncology in Girona

Cuyàs E, Gumuzio J, Verdura S, Brunet J, Bosch-Barrera J, Martin-Castillo B, Alarcón T, Encinar JA, Martin ÁG, Menendez JA

The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes

Aging-Us, 2020, 12, 4794-4814 dx.doi.org/10.18632/aging.102887

Metabolism and Cancer , Precision Oncology in Girona

Verdura S, Cuyàs E, Cortada E, Brunet J, Lopez-Bonet E, Martin-Castillo B, Bosch-Barrera J, Encinar JA, Menendez JA

Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity

Aging-Us, 2020, 12, 8-34 dx.doi.org/10.18632/aging.102646

Metabolism and Cancer , Precision Oncology in Girona

Bosch-Barrera J, Martin-Castillo B, Buxó M, Brunet J, Encinar JA, Menendez JA

Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients

Journal of Clinical Medicine, 2020, 9 dx.doi.org/10.3390/jcm9061770

Metabolism and Cancer , Precision Oncology in Girona

Cuyàs E, Gumuzio J, Lozano-Sánchez J, Segura-Carretero A, Verdura S, Bosch-Barrera J, Martin-Castillo B, Nonell-Canals A, Llebaria A, Cabello S, Serra C, Sanchez-Martinez M, Martin ÁG, Menendez JA

Mimetics of extra virgin olive oil phenols with anti-cancer stem cell activity

Aging-Us, 2020, 12, 21057-21075 dx.doi.org/10.18632/aging.202154

12 3 4 5 6 7 8

Directori

Projectes

Publicacions

Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin

Metformin and breast cancer: an opportunity for pharmacogenetics

Metformin and Breast Cancer: Where Are We Now?

Metformin Is a Pyridoxal-5 '-phosphate (PLP)-Competitive Inhibitor of SHMT2

Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology

Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy

The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes

Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity

Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients

Mimetics of extra virgin olive oil phenols with anti-cancer stem cell activity

Formulari de contacte

About IDIBGI!